These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9474458)

  • 41. Cost-effectiveness and cost containment. A physician's primer.
    Bishof RO; Nash DB
    Prim Care; 1996 Mar; 23(1):115-26. PubMed ID: 8900510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Appropriate, quality imaging tests through linkage of payment to guidelines, accreditation and training.
    Rubin BB; Drenth B; Beanlands RSB
    CMAJ; 2015 Mar; 187(4):E126-E127. PubMed ID: 25157056
    [No Abstract]   [Full Text] [Related]  

  • 43. Value-based Healthcare: Increasing Value by Reducing Implant-related Health Care Costs.
    Waldrop VH; Laverty DC; Bozic KJ
    Clin Orthop Relat Res; 2019 Feb; 477(2):281-283. PubMed ID: 29762154
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness: no easy choices or answers.
    Wilkes M; Hoffman JR
    West J Med; 2000 Dec; 173(6):394-5. PubMed ID: 11112753
    [No Abstract]   [Full Text] [Related]  

  • 45. Doctors and drug companies: still cozy after all these years.
    Henry D
    PLoS Med; 2010 Nov; 7(11):e1000359. PubMed ID: 21072244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?-An Overview.
    Garrison LP
    Value Health; 2016; 19(5):512-5. PubMed ID: 27565265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What a physician needs to know about cost-effectiveness.
    Heidenreich PA; Lee TT
    Cardiol Rev; 2000; 8(2):96-102. PubMed ID: 11174880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bad Medicine: Polypharmacy.
    Spence D
    Br J Gen Pract; 2017 Dec; 67(665):562. PubMed ID: 29192108
    [No Abstract]   [Full Text] [Related]  

  • 49. Ethics Roundtable: "Cost and the Non-Adherent Patient".
    Baumrucker SJ; Macmillan PJ; Stolick M; Adkins RW; Carter GT; York P
    Am J Hosp Palliat Care; 2018 Mar; 35(3):555-559. PubMed ID: 28285541
    [No Abstract]   [Full Text] [Related]  

  • 50. Choosing Wisely: five ideas that physicians and patients can discuss.
    Parke DW; Coleman AL; Rich WL; Lum F
    Ophthalmology; 2013 Mar; 120(3):443-444. PubMed ID: 23714602
    [No Abstract]   [Full Text] [Related]  

  • 51. Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin.
    McKoy JM; Tigue CC; Bennett CL
    Cancer Treat Res; 2008; 140():235-51. PubMed ID: 18283779
    [No Abstract]   [Full Text] [Related]  

  • 52. Rogue Valley Physicians finds innovative ways to provide cost-effective care.
    Kelly H
    MGMA Connex; 2016 Sep; 16(7):40-41. PubMed ID: 30379437
    [No Abstract]   [Full Text] [Related]  

  • 53. Routine diagnostic testing.
    Cameron JD
    Lancet; 1990 Feb; 335(8684):297. PubMed ID: 1967757
    [No Abstract]   [Full Text] [Related]  

  • 54. Rising prescription drug costs: whose responsibility?
    Hill SR; Henry DD; Smith AJ
    Med J Aust; 1997 Jul; 167(1):6-7. PubMed ID: 9236749
    [No Abstract]   [Full Text] [Related]  

  • 55. Changing clinical practice: messages, messengers, and methods.
    Stuart ME
    HMO Pract; 1996 Sep; 10(3):100-2. PubMed ID: 10160283
    [No Abstract]   [Full Text] [Related]  

  • 56. Conflict of interest-draining the swamp means confronting alligators.
    Wyse DG
    J Interv Card Electrophysiol; 2005 Jun; 13(1):5-7. PubMed ID: 15976972
    [No Abstract]   [Full Text] [Related]  

  • 57. Impact of the operating physician on costs of percutaneous transluminal coronary angioplasty.
    Heidenreich PA; Chou TM; Amidon TM; Ports TA; Browner WS
    Am J Cardiol; 1996 Jun; 77(14):1169-73. PubMed ID: 8651090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effective treatment of depression.
    Solomon G
    JAMA; 1995 Jun; 273(23):1833-4. PubMed ID: 7776495
    [No Abstract]   [Full Text] [Related]  

  • 59. Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding.
    Lyman GH; Kuderer NM; Freedland SJ
    J Natl Cancer Inst; 2009 Apr; 101(8):543-5. PubMed ID: 19351926
    [No Abstract]   [Full Text] [Related]  

  • 60. Is there a duty to accept Medicare payment?
    Orient JM
    Arch Intern Med; 1993 Nov; 153(21):2505; author reply 2506. PubMed ID: 8215755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.